Role of GPER on proliferation, migration and invasion in ligand-independent manner in human ovarian cancer cell line SKOV3

被引:39
作者
Yan, Yan [1 ]
Jiang, Xueli [1 ]
Zhao, Ying [1 ]
Wen, Haixia [1 ]
Liu, Guoyi [1 ]
机构
[1] Harbin Med Univ, Dept Physiol, Lab Reprod Endocrinol, Harbin 150081, Peoples R China
关键词
G protein-coupled estrogen receptor; ER alpha; ER beta; ovarian cancer; proliferation; migration; invasion; ESTROGEN-RECEPTOR-ALPHA; G-1 SUPPRESSES PROLIFERATION; GENE-EXPRESSION CHANGES; AGONIST G-1; GROWTH-RESPONSE; BETA; 17-BETA-ESTRADIOL; ACTIVATION; SURVIVAL; PATHWAY;
D O I
10.1002/cbf.3154
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
G protein-coupled estrogen receptor (GPER) is identified as a critical estrogen receptor, in addition to the classical estrogen receptors ER alpha and ER beta. In ER alpha-negative ovarian cancer cells, our previous studies have found that estrogen stimulated cell proliferation and metastasis via GPER. However, the ligand-independent function of GPER in ovarian cancer cells is still not clear. Herein, we describe that GPER has a co-expression with ER alpha and ER beta, which are first determined in SKOV3 ovarian cancer cell line. In the absence of estrogen, GPER depletion by specific siRNA inhibits the proliferation, migration and invasion of SKOV3 cells. Whereas abrogation of ER alpha or ER beta by specific antagonist MPP and PHTPP has the opposite effects for stimulation of cell growth. Markedly, GPER knockdown attenuates MPP or PHTPP-induced cell proliferation, migration and invasion. Furthermore, GPER modulates protein expression of the cell cycle critical components, c-fos and cyclin D1 and factors for cancer cell invasion and metastasis, matrix metalloproteinase 2 (MMP-2) and MMP-9. These findings establish that GPER ligand-independently stimulates the proliferation, migration and invasion of SKOV3 cells. Knockdown of GPER attenuates the progression of ovarian cancer that caused by functional loss of ER alpha or ER beta. Targeting GPER provides new aspect as a potential therapeutic strategy in ovarian cancer. Copyright (C) 2015 John Wiley & Sons, Ltd.
引用
收藏
页码:552 / 559
页数:8
相关论文
共 30 条
[1]   G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17β-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells [J].
Albanito, Lidia ;
Madeo, Antonio ;
Lappano, Rosamaria ;
Vivacqua, Adele ;
Rago, Vittoria ;
Carpino, Amalia ;
Oprea, Tudor I. ;
Prossnitz, Eric R. ;
Musti, Anna Maria ;
Ando, Sebastiano ;
Maggiolini, Marcello .
CANCER RESEARCH, 2007, 67 (04) :1859-1866
[2]   Special Issue: Guide to Receptors and Channels, 5th Edition Abstracts [J].
Alexander, Stephen P. H. ;
Mathie, Alistair ;
Peters, John A. .
BRITISH JOURNAL OF PHARMACOLOGY, 2011, 164 :S1-+
[3]   RETRACTED: Involvement of estrogen receptor β in ovarian carcinogenesis (Retracted article. See vol 65, pg 5480, 2005) [J].
Bardin, A ;
Hoffmann, P ;
Boulle, N ;
Katsaros, D ;
Vignon, F ;
Pujol, P ;
Lazennec, G .
CANCER RESEARCH, 2004, 64 (16) :5861-5869
[4]  
Belotti D, 2003, CANCER RES, V63, P5224
[5]   Prognostic significance of estrogen receptor alpha and beta expression in human serous carcinomas of the ovary [J].
Burges, Alexander ;
Bruening, Ansgar ;
Dannenmann, Christine ;
Blankenstein, Thomas ;
Jeschke, Udo ;
Shabani, Naim ;
Friese, Klaus ;
Mylonas, Ioannis .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2010, 281 (03) :511-517
[6]   Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer [J].
De Stefano, Ilaria ;
Zannoni, Gian Franco ;
Prisco, Maria Grazia ;
Fagotti, Anna ;
Tortorella, Lucia ;
Vizzielli, Giuseppe ;
Mencaglia, Luca ;
Scarnbia, Giovanni ;
Gallo, Daniela .
GYNECOLOGIC ONCOLOGY, 2011, 122 (03) :573-579
[7]   Hallmarks of Cancer: The Next Generation [J].
Hanahan, Douglas ;
Weinberg, Robert A. .
CELL, 2011, 144 (05) :646-674
[8]   Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer [J].
Hasan, J ;
Ton, N ;
Mullamitha, S ;
Clamp, A ;
McNeilly, A ;
Marshall, E ;
Jayson, GC .
BRITISH JOURNAL OF CANCER, 2005, 93 (06) :647-651
[9]   The G protein-coupled oestrogen receptor 1 agonist G-1 disrupts endothelial cell microtubule structure in a receptor-independent manner [J].
Holm, Anders ;
Grande, Per-Olof ;
Luduena, Richard F. ;
Olde, Bjorn ;
Prasad, Veena ;
Leeb-Lundberg, L. M. Fredrik ;
Nilsson, Bengt-Olof .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2012, 366 (1-2) :239-249
[10]   Cancer statistics, 2007 [J].
Jemal, Ahmedin ;
Siegel, Rebecca ;
Ward, Elizabeth ;
Murray, Taylor ;
Xu, Jiaquan ;
Thun, Michael J. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2007, 57 (01) :43-66